A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis

NCT02267642 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriatic Arthritis

Interventions

BIOLOGICAL: AbGn-168H

Sponsor

AbGenomics B.V Taiwan Branch